UNICREDIT BANK/CALL/ELI LILLY & CO/1100/0.1/18.12.24 Stock

Warrant

DE000HD3BKN1

Market Closed - BOERSE MUENCHEN 03:40:07 2024-06-04 pm EDT
1.55 EUR +1.97% Intraday chart for UNICREDIT BANK/CALL/ELI LILLY & CO/1100/0.1/18.12.24
Current month+15.67%
1 month+142.19%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-04 1.55 +1.97%
24-06-03 1.52 +13.43%
24-05-31 1.34 -3.60%
24-05-30 1.39 +4.51%
24-05-29 1.33 +3.10%

Real-time BOERSE MUENCHEN

Last update June 04, 2024 at 03:40 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer UniCredit UniCredit
WKN HD3BKN
ISINDE000HD3BKN1
Date issued 2024-03-04
Strike 1,100 $
Maturity 2024-12-18 (197 Days)
Parity 10 : 1
Emission price 1.78
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.12
Lowest since issue 0.64
Delta0.16x
Omega 8.690
Premium35.97x
Gearing53.3x
Moneyness 0.7458
Difference Strike 267.4 $
Difference Strike %+24.31%
Spread 0.24
Spread %15.58%
Theoretical value 1.490
Implied Volatility 33.33 %
Total Loss Probability 88.63 %
Intrinsic value 0.000000
Present value 1.490
Break even 1,116.15 €
Theta-0.09x
Vega0.14x
Rho0.06x

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
832.6 USD
Average target price
852.5 USD
Spread / Average Target
+2.39%
Consensus